The Maastricht MultiModal Molecular Imaging Institute (M4I) is a state-of-the art molecular imaging institute that brings together a powerful palette of high-end, innovative imaging technologies. The mission of the institute is to perform fundamental, instrumentation and applied studies in molecular imaging as a part of a translational, synergistic, interdisciplinary research programme. M4I aims to be a leading international molecular imaging center relevant for science, education, economy and society. The institute aspires to generate a high-end research environment and a unique knowledge infrastructure, attractive to top researchers from all over the world.
Brightlands is an open innovation community in a global context, connecting four campuses in the province of Limburg: in Maastricht, Heerlen, Sittard-Geleen and Venlo. The campuses provide entrepreneurs, scientists and students state-of-the-art facilities to support development, education, innovation and growth. Naturally, there are close links between all four Brightlands campuses, and together they enable Limburg to serve as an innovation region where researchers and entrepreneurs take on the major challenges in the areas of materials, health, food and smart services.
IMAGES are at the heart of our activities. On a daily basis we are now producing Terabytes of imaging information of molecules, cells and tissues.
It is sometimes easy to forget that at the end of 2019, it was only 5 years ago that this incredible Maastricht adventure started. With the help of many, we were able to build M4i in record time and establish a unique ecosystem that is now part of the Dutch large-scale scientific infrastructure.
This lustrum book reflects on the first five years of the institute, the people and organizations that have contributed to our success.
Click here to download the pdf of the M4i Lustrum Book.
1 - M4I | Division of Nanoscopy
Strives for greater insight into the 3D form of cell proteins, paving the way for developing more effective treatments for diseases such as cancer and tuberculosis while gaining better understanding of how protein complexes manage healthy and diseased cells, allowing drugs and vaccines to work more effectively.
Go to division of Nanoscopy
2 - M4I | Division of Imaging
Developing and applying state-of-the-art mass spectrometry based molecular imaging approaches for nanomedicine and biomedical research, including mass spectrometry as a diagnostic and prognostic tool for personalized medicine in oncology, neurology and cardiovascular medicine. Go to division of IMS
Requests to access the Nanoscopy or Imaging Mass Spectrometry facilities of M4I can be specified using the 'Access to facilities'-contact form. The lab manager of the requested facility will evaluate your request.
The ICARUS project will be carried out in close collaboration with the IMS CORE lab at the M4I division of Imaging Mass Spectrometry, where CriPec® nanoparticle microlocalisation and drug release in tumours will be evaluated.
Interview with prof. Peter Peters on the Science article he co-worked on intensively.
Researchers from the Hubrecht Institute in Utrecht, Erasmus MC University Medical Center Rotterdam, and Maastricht University in the Netherlands have found that the coronavirus SARS-CoV-2, which causes COVID-19, can infect cells of the intestine and multiply there.